vincristine sulfate

Poland

Drugs containing this active substance

  • VINCRISTINE TEVA

    The medicinal product is used for the treatment of, among others, acute lymphoblastic leukemia, Hodgkin's disease, non-Hodgkin lymphomas, lung cancer, sarcomas, adrenocortical carcinoma, Wilms' tumor, metastatic breast cancer, multiple myeloma, retinoblastoma, and hematomas associated with low platelet counts.

    Form: solution for injection

    Active substance Dosage
    vincristine sulfate 1 mg/ml

    ATC: L01CA02

    Manufacturer: Pharmachemie B.V.